Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas

Japanese Journal of Cancer Research

Volumn 88, Issue 10, 1997, Pages 947-952

  Kudo, Yasusei ^a,b   Yasui, Wataru ^a   Ue, Teruyoshi ^a   Yamamoto, Soichiro ^a   Yokozaki, Hiroshi ^a   Nikai, Hiromasa ^b   Tahara, Eiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

CDC25B; Human gastric carcinoma; Overexpression

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; MESSENGER RNA; PHOSPHOPROTEIN PHOSPHATASE;

ADVANCED CANCER; ARTICLE; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NORTHERN BLOTTING; PRIORITY JOURNAL; STOMACH CARCINOMA; TUMOR CELL LINE;

EID: 0030681035     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00313.x     Document Type: Article

References (40)

1. Sherr, C. J. G1 phase progression: cycling on cue. Cell, 79, 515-555 (1994).
2. Hunter, T. and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79, 573-582 (1994).
3. Sherr, C. J. Mammalian G1 cyclins. Cell, 73, 1059-1065 (1993).
4. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Persons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
5. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816 (1993).
6. Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M. and Koff, A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Gene Dev., 8, 9-22 (1994).
7. Toyoshima, H. and Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78, 67-74 (1994).
8. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stocken, E., Day, R. S., Johnson, B. E. and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
9. INK4B is a potent effector of TGF-β-induced cell cycle arrest. Nature, 371, 257-261 (1994).
10. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K. and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756 (1994).
11. Serrano, M., Hannon, G. J. and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707 (1993).
12. + dependent manner. EMBO J., 10, 1255-1263 (1991).
13. Parker, L. L., Atherton-Fessler, S. and Piwnica-Worms, H. p107wee1 is a dual-specificity kinase that phosphorylates p34cdc2 on tyrosine 15. Proc. Natl. Acad. Sci. USA, 89, 2917-2921 (1992).
14. Featherstone, C. and Russell, P. Fission yeast p 107wee1 mitotic inhibitor is a tyrosine/serine kinase. Nature, 349, 808-811 (1991).
15. Dunphy, W. G. and Kumagai, A. The cdc25 protein contains an intrinsic phosphatase activity. Cell, 67, 189-196 (1991).
16. Galaktionov, K. and Beach, D. Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell, 67, 1181-1194 (1991).
17. Gautier, J., Solomon, M., Booher, R., Bazan, J. and Kirshner, M. Cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell, 67, 197-211 (1991).
18. Millar, J. B., McGowan, C. H., Lenaers, G., Jones, R. and Russell, P. p80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast. EMBO J., 10, 4301-4309 (1991).
19. cdc2/cyclin B complex in vitro by human CDC25 protein. Nature, 351, 242-245 (1991).
20. Sadhu, K., Reed, S. I., Richardson, H. and Russell, P. Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. Proc. Natl. Acad. Sci. USA, 87, 5139-5143 (1990).
21. cdc25 is a nuclear protein required for the initiation of mitosis in human cells. Proc. Natl. Acad. Sci. USA, 88, 10500-10504 (1991).
22. Jinno, S., Suto, K., Nagata, A., Igarashi, M., Kanaoka, Y., Nojima, H. and Okayama, H. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J., 13, 1549-1556 (1994).
23. Sebastian, B., Kakizuka, A. and Hunter, T. Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc. Natl. Acad. Sci. USA, 90, 3521-3524 (1993).
24. cdc2 kinase on both Thr-14 and Tyr-15 by human cdc25B phosphatase. FEBS Lett., 318, 331-334 (1993).
25. Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M. and Beach, D. CDC25 phosphatases as potential human oncogenes. Science, 269, 1575-1577 (1995).
26. Ochiai, A., Yasui, W. and Tahara, E. Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn. J. Cancer Res., 76, 1064-1071 (1985).
27. Yanagihara, K., Seyama, T., Tsumuraya, M., Kamada, N. and Yokoro, K. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res., 51, 381-386 (1991).
28. Japanese Research Society for Gastric Cancer. "Japanese Classification of Gastric Carcinoma," 1st English Ed. (1995). Kanehara Co., Tokyo.
29. Yasui, W., Kuniyasu, H., Akama, Y., Kitahara, K., Nagafuchi, A., Ishihara, S., Tsukita, S. and Tahara, E. Expression of E-cadherin, α- and β-catenins in human gastric carcinomas: correlation with histology and tumor progression. Oncol. Rep., 2, 111-117 (1995).
30. Nagata, A., Igarashi, M., Jinno, S., Suto, K. and Okayama, H. An additional homolog of the fission yeast cdc25+ gene occurs in human and is highly expressed in some cancer cells. New Biol., 3, 959-968 (1991).
31. cdc2 and its kinase activity in human gastric and colonic carcinomas. Int. J. Cancer, 53, 36-41 (1993).
32. Yasui, W., Ji, Z.-Q., Kuniyasu, H., Ayhan, A., Yokozaki, H., Ito, H. and Tahara, E. Expression of transforming growth factor alpha in human tissues: immunohistochemical study and Northern blot analysis. Virchows Arch. A [Pathol. Anat]., 21, 513-519 (1992).
33. Mattar, R., Yokozaki, H., Yasui, W., Ito, H. and Tahara, E. p53 gene mutations in gastric cancer cell lines. Life Sci. Adv. Oncol, 11, 7-12 (1992).
34. Ito, R., Kitadai, Y., Kyo, E., Yokozaki, H., Yasui, W., Yamashita, U., Nikai, H. and Tahara, E. Interleukin 1α acts as an autocrine growth stimulator for human gastric carcinoma cells. Cancer Res., 53, 4102-4106 (1993).
35. Yoshida, K., Takanashi, A., Kyo, E., Ito, M., Ito, H., Niimoto, M., Hattori, T. and Tahara, E. Epidermal growth factor induces the expression of its receptor gene in human gastric carcinoma cell line TMK-1. Jpn. J. Cancer Res., 80, 743-746 (1989).
36. Yokozaki, H., Kuniyasu, H., Kitadai, Y., Nishimura, K., Todo, H., Ayhan, A., Yasui, W., Ito, H. and Tahara, E. p53 point mutations in primary human gastric carcinomas. J. Cancer Res. Clin. Oncol., 119, 67-70 (1992).
37. Akama, Y., Yasui, W., Kuniyasu, H., Yokozaki, H., Akagi, M., Tahara, H., Ishikawa, T. and Tahara, E. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Jpn. J. Cancer Res., 87, 824-830 (1996).
38. Tahara, E., Sumiyoshi, H., Hata, J., Yasui, W., Taniyama, K., Hayashi, T., Nagae, S. and Sakamoto, S. Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy. Jpn. J. Cancer Res., 77, 145-152 (1986).
39. Galaktionov, K., Jessus, C. and Beach, D. Rafl interaction with cdc25 phosphatase ties mitogcnic signal transduction to cell cycle activation. Genes Dev., 9, 1046-1058 (1995).
40. Galaktionov, K., Chen, X. and Beach, D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature, 382, 511-517 (1996).